What’s new in the renin-angiotensin system?Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus

被引:0
作者
J. H. Kuhn
W. Li
H. Choe
M. Farzan
机构
[1] Harvard Medical School,Partners AIDS Research Center, Brigham and Women’s Hospital, Department of Medicine (Microbiology and Molecular Genetics)
[2] Harvard Medical School,Perlmutter Laboratory, Pulmonary Division, Children’s Hospital, Department of Pediatrics
[3] Harvard Medical School,Partners AIDS Research Center, Brigham and Women’s Hospital, Department of Medicine (Microbiology and Molecular Genetics)
[4] Freie Universität Berlin,Department of Biology, Chemistry, Pharmacy
来源
Cellular and Molecular Life Sciences CMLS | 2004年 / 61卷
关键词
Severe acute respiratory syndrome; SARS; coronavirus; angiotensin-converting enzyme 2; ACE2; viral fusion;
D O I
暂无
中图分类号
学科分类号
摘要
Cellular entry of enveloped viruses is often dependent on attachment proteins expressed on the host cell surface. Viral envelope proteins bind these receptors, and, in an incompletely understood process, facilitate fusion of the cellular and viral membranes so as to introduce the viral core into the cytoplasm. Only a small fraction of viral receptors have been identified so far. Recently, a novel coronavirus was identified as the etiological agent of severe acute respiratory syndrome (SARS). The fusion protein gene of SARS coronavirus (SARS-CoV) was cloned and characterized, and shortly thereafter, angiotensin-converting enzyme 2 (ACE2) was shown to be its functional receptor. Identification of ACE2 as a receptor for SARS-CoV will likely contribute to the development of antivirals and vaccines. It may also contribute to the development of additional animal models for studying SARS pathogenesis, and could help identify the animal reservoir of SARS-CoV.
引用
收藏
页码:2738 / 2743
页数:5
相关论文
共 50 条
  • [21] Therapeutic targeting of the angiotensin-converting enzyme 2/Angiotensin-(1-7)/Mas cascade in the renin-angiotensin system: a patent review
    Ferreira, Anderson J.
    Bader, Michael
    Santos, Robson A. S.
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2012, 22 (05) : 567 - 574
  • [22] THE ACTIVITY OF ANGIOTENSIN-CONVERTING ENZYME 2 AND OTHER COMPONENTS OF THE RENIN-ANGIOTENSIN SYSTEM (RAAS) DURING PROGRESSIVE AGE IN HYPERTENSIVE MEN
    Hasan, Methaq Mohamed
    Khalifa, Ahmed Aboud
    PERIODICO TCHE QUIMICA, 2023, 20 (43): : 12 - 25
  • [23] Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions
    Burchill, Luke J.
    Velkoska, Elena
    Dean, Rachael G.
    Griggs, Karen
    Patel, Sheila K.
    Burrell, Louise M.
    CLINICAL SCIENCE, 2012, 123 (11-12) : 649 - 658
  • [24] Overexpression of angiotensin-converting enzyme 2 by renin-angiotensin system inhibitors. Truth or myth? A systematic review of animal studies
    Kai, Hisashi
    Kai, Mamiko
    Niiyama, Hiroshi
    Okina, Norihito
    Sasaki, Motoki
    Maeda, Takanobu
    Katoh, Atsushi
    HYPERTENSION RESEARCH, 2021, 44 (08) : 955 - 968
  • [25] Angiotensin-converting enzyme as a new immunologic target for the new SARS-CoV-2
    Hallaj, Shahin
    Ghorbani, Anahita
    Mousavi-Aghdas, Seyed Ali
    Mirza-Aghazadeh-Attari, Mohammad
    Sevbitov, Andrey
    Hashemi, Vida
    Hallaj, Tooba
    Jadidi-Niaragh, Farhad
    IMMUNOLOGY AND CELL BIOLOGY, 2021, 99 (02) : 192 - 205
  • [26] Conversion of Aβ43 to Aβ40 by the Successive Action of Angiotensin-Converting Enzyme 2 and Angiotensin-Converting Enzyme
    Liu, Shuyu
    Liu, Junjun
    Miura, Yukie
    Tanabe, Chiaki
    Maeda, Tomoji
    Terayama, Yasuo
    Turner, Anthony J.
    Zou, Kun
    Komano, Hiroto
    JOURNAL OF NEUROSCIENCE RESEARCH, 2014, 92 (09) : 1178 - 1186
  • [27] Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update
    Shukla, Ashwin Kumar
    Banerjee, Monisha
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2021, 28 (02) : 129 - 139
  • [28] Influence of renin-angiotensin-aldosterone system inhibitors on plasma levels of angiotensin-converting enzyme 2
    Zimmermann, Tobias
    Walter, Joan Elias
    Lopez-Ayala, Pedro
    Strebel, Ivo
    Amrein, Melissa
    Koechlin, Michael
    Honegger, Ursina
    Mueller, Christian
    ESC HEART FAILURE, 2021, 8 (02): : 1717 - 1721
  • [29] Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Angiotensin-Converting Enzyme 2 Levels: A Comprehensive Analysis Based on Animal Studies
    Kriszta, Gabor
    Kriszta, Zsofia
    Vancsa, Szilard
    Hegyi, Peter Jeno
    Frim, Levente
    Eross, Balint
    Hegyi, Peter
    Petho, Gabor
    Pinter, Erika
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [30] Angiotensin-Converting Enzyme 2 (SARS-CoV-2 receptor) expression in human skeletal muscle
    Perez-Valera, Mario
    Martinez-Canton, Miriam
    Gallego-Selles, Angel
    Galvan-Alvarez, Victor
    Gelabert-Rebato, Miriam
    Morales-Alamo, David
    Santana, Alfredo
    Martin-Rodriguez, Saul
    Ponce-Gonzalez, Jesus Gustavo
    Larsen, Steen
    Losa-Reyna, Jose
    Perez-Suarez, Ismael
    Dorado, Cecilia
    Curtelin, David
    Gonzalez-Henriquez, Juan Jose
    Boushel, Robert
    Hallen, Jostein
    de Pablos Velasco, Pedro
    Freixinet-Gilart, Jorge
    Holmberg, Hans-Christer
    Helge, Jorn W.
    Martin-Rincon, Marcos
    Calbet, Jose A. L.
    SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS, 2021, 31 (12) : 2249 - 2258